Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
33.00
-0.65 (-1.92%)
Nov 5, 2024, 1:19 PM EST - Market open
Castle Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 311.88 | 219.79 | 137.04 | 94.09 | 62.65 | 51.87 | Upgrade
|
| Revenue Growth (YoY) | 62.43% | 60.38% | 45.65% | 50.18% | 20.79% | 127.62% | Upgrade
|
| Cost of Revenue | 56.45 | 44.98 | 32.01 | 15.82 | 9.69 | 7.31 | Upgrade
|
| Gross Profit | 255.43 | 174.81 | 105.03 | 78.26 | 52.96 | 44.56 | Upgrade
|
| Selling, General & Admin | 194.17 | 180.15 | 143 | 86.74 | 48.13 | 29.84 | Upgrade
|
| Research & Development | 53.26 | 53.62 | 44.9 | 29.65 | 13.26 | 7.39 | Upgrade
|
| Operating Expenses | 256.47 | 242.78 | 196.17 | 118.34 | 61.39 | 37.23 | Upgrade
|
| Operating Income | -1.04 | -67.98 | -91.14 | -40.08 | -8.42 | 7.33 | Upgrade
|
| Interest Expense | -0.49 | -0.01 | -0.02 | -0 | -2.63 | -4.57 | Upgrade
|
| Interest & Investment Income | 12.66 | 10.62 | 3.97 | 0.07 | 0.37 | 0.31 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | -2.93 | Upgrade
|
| EBT Excluding Unusual Items | 11.14 | -57.37 | -87.19 | -40.01 | -10.69 | 0.14 | Upgrade
|
| Other Unusual Items | - | - | 18.29 | - | 0.49 | 5.21 | Upgrade
|
| Pretax Income | 11.14 | -57.37 | -68.9 | -40.01 | -10.2 | 5.35 | Upgrade
|
| Income Tax Expense | 5.06 | 0.1 | -1.77 | -8.72 | 0.08 | 0.07 | Upgrade
|
| Net Income | 6.08 | -57.47 | -67.14 | -31.29 | -10.28 | 5.28 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 2.29 | Upgrade
|
| Net Income to Common | 6.08 | -57.47 | -67.14 | -31.29 | -10.28 | 2.99 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 27 | 26 | 25 | 19 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 27 | 26 | 25 | 19 | 9 | Upgrade
|
| Shares Change (YoY) | 6.54% | 2.87% | 3.65% | 32.80% | 118.63% | 354.25% | Upgrade
|
| EPS (Basic) | 0.22 | -2.14 | -2.58 | -1.24 | -0.54 | 0.35 | Upgrade
|
| EPS (Diluted) | 0.21 | -2.14 | -2.58 | -1.24 | -0.54 | -0.21 | Upgrade
|
| Free Cash Flow | 34.54 | -19.25 | -47.29 | -22.47 | 5.11 | 6.08 | Upgrade
|
| Free Cash Flow Per Share | 1.22 | -0.72 | -1.81 | -0.89 | 0.27 | 0.70 | Upgrade
|
| Gross Margin | 81.90% | 79.53% | 76.64% | 83.18% | 84.54% | 85.91% | Upgrade
|
| Operating Margin | -0.33% | -30.93% | -66.51% | -42.60% | -13.45% | 14.13% | Upgrade
|
| Profit Margin | 1.95% | -26.15% | -48.99% | -33.26% | -16.42% | 5.77% | Upgrade
|
| Free Cash Flow Margin | 11.07% | -8.76% | -34.51% | -23.88% | 8.16% | 11.72% | Upgrade
|
| EBITDA | 12.42 | -55.65 | -80.6 | -36.67 | -7.95 | 7.69 | Upgrade
|
| EBITDA Margin | 3.98% | -25.32% | -58.81% | -38.98% | -12.69% | 14.82% | Upgrade
|
| D&A For EBITDA | 13.45 | 12.33 | 10.54 | 3.41 | 0.47 | 0.36 | Upgrade
|
| EBIT | -1.04 | -67.98 | -91.14 | -40.08 | -8.42 | 7.33 | Upgrade
|
| EBIT Margin | -0.33% | -30.93% | -66.51% | -42.60% | -13.45% | 14.13% | Upgrade
|
| Effective Tax Rate | 45.46% | - | - | - | - | 1.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.